Stocks · Sector
Healthcare Stocks - Prices & Analysis (1,175)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| The Oncology Institute, Inc. | STLN | $5.93 | $604.36M | — | |
| Tectonic Therapeutic, Inc. | TECX | $30.75 | $601.14M | — | |
| Zura Bio Limited | ZURA | $6.23 | $597.02M | — | |
| Autolus Therapeutics plc | AUTL | $2.24 | $596.20M | — | |
| REGENXBIO Inc. | RGNX | $8.94 | $590.16M | — | |
| Cabaletta Bio, Inc. | CABA | $3.47 | $588.32M | — | |
| Eikon Therapeutics, Inc. | EIKN | $10.86 | $588.23M | — | |
| Weave Communications, Inc. | WEAV | $7.33 | $586.39M | — | |
| OrthoPediatrics Corp. Common Stock | KIDS | $22.41 | $585.12M | — | |
| Delcath Systems, Inc. | DCTH | $16.48 | $571.84M | 1,648.0 | — |
| BrainsWay Ltd. | BWAY | $14.15 | $568.94M | 64.3 | — |
| ARS Pharmaceuticals, Inc. | SPRY | $5.62 | $558.89M | — | |
| Eupraxia Pharmaceuticals Inc. | EPRX | $8.40 | $555.02M | — | |
| Artiva Biotherapeutics, Inc. | ARTV | $11.19 | $547.08M | — | |
| Ovid Therapeutics Inc. | OVID | $2.80 | $546.83M | — | |
| Capricor Therapeutics, Inc. | CAPR | $9.40 | $546.51M | — | |
| Fulgent Genetics, Inc. | FLGT | $19.73 | $542.88M | — | |
| Scribe Therapeutics Inc. | SCTX | $28.67 | $542.77M | — | |
| Cerus Corporation | CERS | $2.59 | $521.95M | — | |
| Entera Bio Ltd. | ENTX | $3.00 | $519.43M | — | |
| NeuroPace, Inc. | NPCE | $14.90 | $511.43M | — | |
| Kyverna Therapeutics, Inc. | KYTX | $8.25 | $510.21M | — | |
| Vitalhub Corp. | VHI.TO | CA$8.04 | CA$509.25M | 67.0 | — |
| Senseonics Holdings, Inc. | SENS | $9.63 | $509.18M | — | |
| Prothena Corporation plc | PRTA | $9.82 | $504.13M | — | |
| Editas Medicine, Inc. | EDIT | $3.23 | $496.06M | — | |
| Tactile Systems Technology, Inc. | TCMD | $21.87 | $495.41M | 20.6 | — |
| Puma Biotechnology, Inc. | PBYI | $9.55 | $492.97M | 18.7 | — |
| Kamada Ltd. | KMDA | $8.54 | $492.71M | 21.9 | 2.05% |
| Evolent Health, Inc. | EVH | $4.32 | $488.42M | — | |
| NRC Health | NRC | $21.53 | $476.23M | 89.7 | 3.01% |
| Relmada Therapeutics, Inc. | RLMD | $4.43 | $472.55M | — | |
| Vogenx, Inc. | VOGX | $31.73 | $471.35M | — | |
| Strata Critical Medical, Inc. | SRTA | $5.32 | $470.64M | — | |
| Ginkgo Bioworks Holdings, Inc. | DNA | $6.95 | $468.01M | — | |
| Atea Pharmaceuticals, Inc. | AVIR | $5.83 | $467.59M | — | |
| Galectin Therapeutics Inc. | GALT | $4.61 | $464.92M | — | |
| C4 Therapeutics, Inc. | CCCC | $3.76 | $462.57M | — | |
| Ocugen, Inc. | OCGN | $1.36 | $461.19M | — | |
| Sight Sciences, Inc. | SGHT | $8.35 | $459.98M | — | |
| Arcturus Therapeutics Holdings Inc. | ARCT | $15.82 | $449.65M | — | |
| Evommune, Inc. | EVMN | $12.27 | $445.30M | — | |
| Rezolute, Inc. | RZLT | $4.58 | $441.02M | — | |
| BioAge Labs, Inc. | BIOA | $9.59 | $440.15M | — | |
| Prelude Therapeutics Incorporated | PRLD | $5.46 | $435.73M | — | |
| Benitec Biopharma Inc. | BNTC | $12.68 | $435.61M | — | |
| Fennec Pharmaceuticals Inc. Common Stock | FENC | $12.39 | $434.48M | — | |
| Compass Therapeutics, Inc. | CMPX | $2.38 | $428.61M | — | |
| Cross Country Healthcare Inc | CCRN | $13.25 Jul 28, 2026 | $428.06M | — | |
| Carlsmed, Inc. | CARL | $15.60 | $425.92M | — |
The Oncology Institute, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $604.36M
- P/E
- unprofitable
Tectonic Therapeutic, Inc.
Healthcare / Biotechnology
- Market Cap
- $601.14M
- P/E
- unprofitable
Zura Bio Limited
Healthcare / Biotechnology
- Market Cap
- $597.02M
- P/E
- unprofitable
Autolus Therapeutics plc
Healthcare / Biotechnology
- Market Cap
- $596.20M
- P/E
- unprofitable
REGENXBIO Inc.
Healthcare / Biotechnology
- Market Cap
- $590.16M
- P/E
- unprofitable
Cabaletta Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $588.32M
- P/E
- unprofitable
Eikon Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $588.23M
- P/E
- unprofitable
Weave Communications, Inc.
Healthcare / Health Information Services
- Market Cap
- $586.39M
- P/E
- unprofitable
OrthoPediatrics Corp. Common Stock
Healthcare / Medical Devices
- Market Cap
- $585.12M
- P/E
- unprofitable
Delcath Systems, Inc.
Healthcare / Medical Devices
- Market Cap
- $571.84M
- P/E
- 1,648.0
BrainsWay Ltd.
Healthcare / Medical Devices
- Market Cap
- $568.94M
- P/E
- 64.3
ARS Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $558.89M
- P/E
- unprofitable
Eupraxia Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- $555.02M
- P/E
- unprofitable
Artiva Biotherapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $547.08M
- P/E
- unprofitable
Ovid Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $546.83M
- P/E
- unprofitable
Capricor Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $546.51M
- P/E
- unprofitable
Fulgent Genetics, Inc.
Healthcare / Diagnostics & Research
- Market Cap
- $542.88M
- P/E
- unprofitable
Scribe Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $542.77M
- P/E
- unprofitable
Cerus Corporation
Healthcare / Medical Devices
- Market Cap
- $521.95M
- P/E
- unprofitable
Entera Bio Ltd.
Healthcare / Biotechnology
- Market Cap
- $519.43M
- P/E
- unprofitable
NeuroPace, Inc.
Healthcare / Medical Devices
- Market Cap
- $511.43M
- P/E
- unprofitable
Kyverna Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $510.21M
- P/E
- unprofitable
Vitalhub Corp.
Healthcare / Health Information Services
- Market Cap
- CA$509.25M
- P/E
- 67.0
Senseonics Holdings, Inc.
Healthcare / Medical Devices
- Market Cap
- $509.18M
- P/E
- unprofitable
Prothena Corporation plc
Healthcare / Biotechnology
- Market Cap
- $504.13M
- P/E
- unprofitable
Editas Medicine, Inc.
Healthcare / Biotechnology
- Market Cap
- $496.06M
- P/E
- unprofitable
Tactile Systems Technology, Inc.
Healthcare / Medical Devices
- Market Cap
- $495.41M
- P/E
- 20.6
Puma Biotechnology, Inc.
Healthcare / Biotechnology
- Market Cap
- $492.97M
- P/E
- 18.7
Kamada Ltd.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $492.71M
- P/E
- 21.9
- Dividend Yield
- 2.05%
Evolent Health, Inc.
Healthcare / Health Information Services
- Market Cap
- $488.42M
- P/E
- unprofitable
NRC Health
Healthcare / Health Information Services
- Market Cap
- $476.23M
- P/E
- 89.7
- Dividend Yield
- 3.01%
Relmada Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $472.55M
- P/E
- unprofitable
Vogenx, Inc.
Healthcare / Biotechnology
- Market Cap
- $471.35M
- P/E
- unprofitable
Strata Critical Medical, Inc.
Healthcare / Medical Care Facilities
- Market Cap
- $470.64M
- P/E
- unprofitable
Ginkgo Bioworks Holdings, Inc.
Healthcare / Biotechnology
- Market Cap
- $468.01M
- P/E
- unprofitable
Atea Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $467.59M
- P/E
- unprofitable
Galectin Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $464.92M
- P/E
- unprofitable
C4 Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $462.57M
- P/E
- unprofitable
Ocugen, Inc.
Healthcare / Biotechnology
- Market Cap
- $461.19M
- P/E
- unprofitable
Sight Sciences, Inc.
Healthcare / Medical Devices
- Market Cap
- $459.98M
- P/E
- unprofitable
Arcturus Therapeutics Holdings Inc.
Healthcare / Biotechnology
- Market Cap
- $449.65M
- P/E
- unprofitable
Evommune, Inc.
Healthcare / Biotechnology
- Market Cap
- $445.30M
- P/E
- unprofitable
Rezolute, Inc.
Healthcare / Biotechnology
- Market Cap
- $441.02M
- P/E
- unprofitable
BioAge Labs, Inc.
Healthcare / Drug Manufacturers - Specialty & Generic
- Market Cap
- $440.15M
- P/E
- unprofitable
Prelude Therapeutics Incorporated
Healthcare / Biotechnology
- Market Cap
- $435.73M
- P/E
- unprofitable
Benitec Biopharma Inc.
Healthcare / Biotechnology
- Market Cap
- $435.61M
- P/E
- unprofitable
Fennec Pharmaceuticals Inc. Common Stock
Healthcare / Biotechnology
- Market Cap
- $434.48M
- P/E
- unprofitable
Compass Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $428.61M
- P/E
- unprofitable
Cross Country Healthcare Inc
Healthcare / Medical Care Facilities
- Market Cap
- $428.06M
- P/E
- unprofitable
Carlsmed, Inc.
Healthcare / Health Information Services
- Market Cap
- $425.92M
- P/E
- unprofitable
Showing 501–550 of 1,175 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.